Lattice Biologics Ltd LBLTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.01 / $0.45
- Market Cap
- $128.22
- Volume/Avg
- 1,000 / 4,250
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- http://www.latticebiologics.com
Valuation
|
Metric
|
LBLTF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
LBLTF
Financial Strength
|
Metric
|
LBLTF
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | −0.59 |
Quick Ratio
LBLTF
Profitability
|
Metric
|
LBLTF
|
|---|---|
Return on Assets (Normalized) | −49.18% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
LBLTF
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gpmqzqtq | Tsrgs | $185.5 Bil | |
SYK
| Stryker Corp | Pfqfvhmfg | Wwsqn | $128.2 Bil | |
MDT
| Medtronic PLC | Lbzdhwbv | Mskhf | $106.7 Bil | |
BSX
| Boston Scientific Corp | Kqkswmwpq | Ltswy | $99.0 Bil | |
DXCM
| DexCom Inc | Kfkjfwqg | Yjzk | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Kwhkpwbt | Qpzhlfc | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Xgnbhgwpd | Fkfq | $24.9 Bil | |
ALGN
| Align Technology Inc | Ghzlqtby | Mxhzsm | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Vrwrjrnd | Jctxccd | $18.9 Bil | |
PODD
| Insulet Corp | Rhwmcnrb | Vvrkc | $11.7 Bil |